Perceptive Life Sciences Master Fund Ltd - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYA Sciences Acquisition Corp II (ARYBU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Athira Pharma Inc (ATHA) with a net purchase of 605,686. Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 77,596 shares made by Andrew Gengos , a net sale of 9,640 shares made by Mark James Litton , and a net sale of 4,824 shares made by Rachel Lenington .

In summary, during the past 3 months, insiders sold 0 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,528 shares of Athira Pharma Inc (ATHA) were sold and 800,698 shares were bought by its insiders, resulting in a net purchase of 774,170 shares.

Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Quotient Ltd (QTNTQ) with a net sale of 8,255,607. Other recent insider transactions involving Quotient Ltd (QTNTQ) include a net sale of 25,000 shares made by Prondzynski Heino Von , a net sale of 1,014 shares made by Isabelle Buckle ,

In summary, during the past 3 months, insiders sold 0 shares of Quotient Ltd (QTNTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 232,404 shares of Quotient Ltd (QTNTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 232,404 shares.

Quotient Ltd (QTNTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Athenex Inc (ATNXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Athenex Inc (ATNXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Athenex Inc (ATNXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Albireo Pharma Inc (ALBO). Other recent insider transactions involving Albireo Pharma Inc (ALBO) include a net sale of 2,814 shares made by Pamela Stephenson , a net sale of 3,285 shares made by Jan Mattsson , and a net sale of 1,878 shares made by Harford Simon N.r. .

In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,134 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,134 shares.

Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 3 insider transaction in Aldeyra Therapeutics Inc (ALDX) with a net sale of 2,074,234. Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 41,305 shares made by Stephen Machatha , a net sale of 26,402 shares made by Bruce Greenberg , and a net sale of 183,238 shares made by Todd C Brady .

In summary, during the past 3 months, insiders sold 250,945 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 682,265 shares, with a net purchase of 431,320 shares. During the past 18 months, 3,007,444 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,325,179 shares.

Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Leap Therapeutics Inc (LPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Leap Therapeutics Inc (LPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Leap Therapeutics Inc (LPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 33,000 shares made by Patrick G Lepore , and a net purchase of 10,000 shares made by Mutya Harsch .

In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 43,000 shares were bought by its insiders, resulting in a net purchase of 43,000 shares.

VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Lyra Therapeutics Inc (LYRA) with a net purchase of 3,610,832. Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 1,805,416 shares made by Nbvm Gp, Llc , a net purchase of 1,805,416 shares made by Edward T Anderson , and a net purchase of 25,000 shares made by Harlan Waksal .

In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.

Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in VBI Vaccines Inc (VBIV) with a net sale of 10,894,749. Other recent insider transactions involving VBI Vaccines Inc (VBIV) include a net purchase of 609,090 shares made by Steven Gillis ,

In summary, during the past 3 months, insiders sold 0 shares of VBI Vaccines Inc (VBIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 363,158 shares of VBI Vaccines Inc (VBIV) were sold and 609,090 shares were bought by its insiders, resulting in a net purchase of 245,932 shares.

VBI Vaccines Inc (VBIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Crinetics Pharmaceuticals Inc (CRNX). Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 42,092 shares made by Stephen F. Betz , a net sale of 61,634 shares made by Dana Pizzuti , and a net sale of 340,951 shares made by Richard Scott Struthers .

In summary, during the past 3 months, insiders sold 187,216 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 187,216 shares. During the past 18 months, 619,400 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 614,400 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in ADMA Biologics Inc (ADMA). Other recent insider transactions involving ADMA Biologics Inc (ADMA) include a net sale of 730,507 shares made by Adam S Grossman , a net sale of 1,500,000 shares made by Steve Elms , and a net sale of 382,769 shares made by Brian Lenz .

In summary, during the past 3 months, insiders sold 1,500,000 shares of ADMA Biologics Inc (ADMA) in total and bought 0 shares, with a net sale of 1,500,000 shares. During the past 18 months, 4,083,538 shares of ADMA Biologics Inc (ADMA) were sold and 191,958 shares were bought by its insiders, resulting in a net sale of 3,891,580 shares.

ADMA Biologics Inc (ADMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Agile Therapeutics Inc (AGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agile Therapeutics Inc (AGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Agile Therapeutics Inc (AGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Kadmon Holdings Inc (KDMN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kadmon Holdings Inc (KDMN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kadmon Holdings Inc (KDMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dova Pharmaceuticals Inc (DOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dova Pharmaceuticals Inc (DOVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dova Pharmaceuticals Inc (DOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in MeiraGTx Holdings PLC (MGTX) with a net purchase of 4,347,826.

In summary, during the past 3 months, insiders sold 0 shares of MeiraGTx Holdings PLC (MGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MeiraGTx Holdings PLC (MGTX) were sold and 4,347,826 shares were bought by its insiders, resulting in a net purchase of 4,347,826 shares.

MeiraGTx Holdings PLC (MGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Foamix Pharmaceuticals Ltd (FOMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Foamix Pharmaceuticals Ltd (FOMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Foamix Pharmaceuticals Ltd (FOMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Solid Biosciences Inc (SLDB) with a net purchase of 3,410,713. Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 3,291 shares made by Ilan Ganot , a net purchase of 904,160 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 5,367 shares made by David T Howton .

In summary, during the past 3 months, insiders sold 139 shares of Solid Biosciences Inc (SLDB) in total and bought 0 shares, with a net sale of 139 shares. During the past 18 months, 25,771 shares of Solid Biosciences Inc (SLDB) were sold and 4,314,873 shares were bought by its insiders, resulting in a net purchase of 4,289,102 shares.

Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Motus GI Holdings Inc (MOTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Motus GI Holdings Inc (MOTS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Motus GI Holdings Inc (MOTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 645,546 shares made by John F Crowley , a net sale of 258,416 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .

In summary, during the past 3 months, insiders sold 185,169 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 185,169 shares. During the past 18 months, 1,242,298 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,242,298 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of La Jolla Pharmaceutical Co (LJPC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of La Jolla Pharmaceutical Co (LJPC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

La Jolla Pharmaceutical Co (LJPC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Corium International Inc (CORI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corium International Inc (CORI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Corium International Inc (CORI)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 3 insider transaction in Verrica Pharmaceuticals Inc (VRCA) with a net purchase of 2,060,199. Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net sale of 84,376 shares made by Ted White , a net sale of 71,108 shares made by Joe Bonaccorso , and a net sale of 67,488 shares made by Christopher G. Hayes .

In summary, during the past 3 months, insiders sold 0 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 288,608 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,971,591 shares.

Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Talphera Inc (TLPH). Other recent insider transactions involving Talphera Inc (TLPH) include a net purchase of 20,000 shares made by Vincent J. Angotti , and a net sale of 16,956 shares made by Pamela P Palmer .

In summary, during the past 3 months, insiders sold 0 shares of Talphera Inc (TLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,956 shares of Talphera Inc (TLPH) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 3,044 shares.

Talphera Inc (TLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aegerion Pharmaceuticals Inc (AEGR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aegerion Pharmaceuticals Inc (AEGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aegerion Pharmaceuticals Inc (AEGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .

In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.

Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XTL Biopharmaceuticals Ltd (XTLB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XTL Biopharmaceuticals Ltd (XTLB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XTL Biopharmaceuticals Ltd (XTLB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in ANI Pharmaceuticals Inc (ANIP). Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 626,190 shares made by Muthusamy Shanmugam , a net sale of 140,000 shares made by Chad Gassert , and a net sale of 1,500 shares made by Meredith Cook .

In summary, during the past 3 months, insiders sold 230,132 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 230,132 shares. During the past 18 months, 1,371,108 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,371,108 shares.

ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of SCYNEXIS Inc (SCYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SCYNEXIS Inc (SCYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SCYNEXIS Inc (SCYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 4 insider transaction in Astria Therapeutics Inc (ATXS) with a net purchase of 5,204,223. Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net sale of 20,000 shares made by Christopher Morabito ,

In summary, during the past 3 months, insiders sold 20,000 shares of Astria Therapeutics Inc (ATXS) in total and bought 2,481,350 shares, with a net purchase of 2,461,350 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 5,204,223 shares were bought by its insiders, resulting in a net purchase of 5,184,223 shares.

Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of IsoPlexis Corp (ISO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of IsoPlexis Corp (ISO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

IsoPlexis Corp (ISO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Prometheus Biosciences Inc (RXDX). Other recent insider transactions involving Prometheus Biosciences Inc (RXDX) include a net sale of 125,000 shares made by Mark C. Mckenna , a net sale of 30,000 shares made by Keith W Marshall , and a net sale of 865,000 shares made by Cedars Sinai Intellectual Property Co .

In summary, during the past 3 months, insiders sold 0 shares of Prometheus Biosciences Inc (RXDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,020,000 shares of Prometheus Biosciences Inc (RXDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,020,000 shares.

Prometheus Biosciences Inc (RXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang , a net purchase of 164,881 shares made by Franklin M Berger , and a net purchase of 1,710,358 shares made by Biotechnology Value Fund L P .

In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168,973 shares of Rain Oncology Inc (RAIN) were sold and 4,219,869 shares were bought by its insiders, resulting in a net purchase of 3,050,896 shares.

Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Landos Biopharma Inc (LABP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Landos Biopharma Inc (LABP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Landos Biopharma Inc (LABP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Cerevel Therapeutics Holdings Inc (CERE) with a net purchase of 876,808. Other recent insider transactions involving Cerevel Therapeutics Holdings Inc (CERE) include a net sale of 802,506 shares made by N Anthony Coles , a net sale of 37,652 shares made by Ramiro Sanchez , and a net sale of 27,161 shares made by John Renger .

In summary, during the past 3 months, insiders sold 154,667 shares of Cerevel Therapeutics Holdings Inc (CERE) in total and bought 0 shares, with a net sale of 154,667 shares. During the past 18 months, 1,166,157 shares of Cerevel Therapeutics Holdings Inc (CERE) were sold and 17,422,701 shares were bought by its insiders, resulting in a net purchase of 16,256,544 shares.

Cerevel Therapeutics Holdings Inc (CERE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Nautilus Biotechnology Inc (NAUT). Other recent insider transactions involving Nautilus Biotechnology Inc (NAUT) include a net purchase of 50,000 shares made by Sujal M Patel ,

In summary, during the past 3 months, insiders sold 0 shares of Nautilus Biotechnology Inc (NAUT) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 0 shares of Nautilus Biotechnology Inc (NAUT) were sold and 50,000 shares were bought by its insiders, resulting in a net purchase of 50,000 shares.

Nautilus Biotechnology Inc (NAUT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of LianBio (LIANY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LianBio (LIANY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

LianBio (LIANY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Acrivon Therapeutics Inc (ACRV) with a net purchase of 2,353,000. Other recent insider transactions involving Acrivon Therapeutics Inc (ACRV) include a net purchase of 392,035 shares made by Chione Ltd , a net purchase of 3,389,500 shares made by Ra Capital Healthcare Fund Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Acrivon Therapeutics Inc (ACRV) in total and bought 2,353,000 shares, with a net purchase of 2,353,000 shares. During the past 18 months, 7,965 shares of Acrivon Therapeutics Inc (ACRV) were sold and 6,142,500 shares were bought by its insiders, resulting in a net purchase of 6,134,535 shares.

Acrivon Therapeutics Inc (ACRV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 5 insider transaction in Soleno Therapeutics Inc (SLNO) with a net purchase of 1,210,087. Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net sale of 196,136 shares made by Bhatnagar Anish , a net sale of 52,057 shares made by Kristen Yen , and a net sale of 20,498 shares made by Patricia C Hirano .

In summary, during the past 3 months, insiders sold 28,591 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 28,591 shares. During the past 18 months, 748,686 shares of Soleno Therapeutics Inc (SLNO) were sold and 1,210,087 shares were bought by its insiders, resulting in a net purchase of 461,401 shares.

Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.